Why it exists
Regulations and guidelines explain what is expected, but professionals still have to translate those expectations into procedures, records, investigations, controls and management decisions. Pharma Ops Academy focuses on that translation—from requirement to reliable routine.
The perspective is international and GMP-first, with particular attention to the operating realities of manufacturers in Africa and other emerging markets. Content is designed for production, QA, QC, regulatory, engineering, supply-chain, finance and leadership teams.
Founder
S. BHATTI
Registered Pharmacist / Pharmaceutical Operations Leader
The Academy's perspective is shaped by practical responsibility across pharmaceutical manufacturing, quality systems, regulatory work, supply chain, engineering, costing and operational decision-making. The aim is not to repeat guidance text, but to explain how separate requirements connect when real work, evidence and risk must be managed.
S. BHATTI founded Pharma Ops Academy on the belief that patient protection, compliance and operational performance reinforce one another when requirements are understood clearly and implemented as usable systems.
How content is developed
- Use current primary regulatory and technical sources wherever possible.
- Identify the jurisdiction or framework behind regulatory statements.
- Separate mandatory requirements from recommended good practice.
- Connect the requirement to practical evidence, decisions and examples.
- Date substantive guidance and review it when source requirements change.
- Never publish confidential employer, client, product or inspection information.
Source and review standard
Each substantive guide identifies its primary references and the date on which they were accessed. Sources are selected from regulators, pharmacopoeial or standards-setting organizations before secondary commentary. Readers should always verify the current version applicable to their jurisdiction, product and approved quality system.
Publication and update dates are shown where they help readers judge currency. A change to a source, an identified factual error or a material improvement to the practical guidance can trigger review.
Independence, limitations and corrections
Content is educational and does not replace regulatory advice, product-specific scientific assessment or an organization's approved procedures. Illustrative examples are simplified and are not presented as confidential cases from a named company or inspection.
Corrections and well-supported challenges are welcome. Send the page URL, the passage concerned and a reliable supporting source to pharmaopsacademy@gmail.com. Any future sponsorship or commercial relationship capable of influencing a resource will be disclosed clearly.
Editorial approach last reviewed: 16 October 2026